Glucose Control in Type I Diabetic Patients: A Volterra Model-Based Approach

2004 ◽  
Vol 37 (1) ◽  
pp. 353-358
Author(s):  
Justin D. Rubb ◽  
Robert S. Parker
2011 ◽  
Vol 44 (1) ◽  
pp. 7114-7119 ◽  
Author(s):  
Levente Kovács ◽  
Péter Szalay ◽  
Zsuzsanna Almássy ◽  
Zoltán Benyo ◽  
László Barkai

1994 ◽  
Vol 33 (01) ◽  
pp. 103-110 ◽  
Author(s):  
S. Andreassen

Abstract:Two relatively new approaches to model-based biosignal interpretation, qualitative simulation and modelling by causal probabilistic networks, are compared to modelling by differential equations. A major problem in applying a model to an individual patient is the estimation of the parameters. The available observations are unlikely to allow a proper estimation of the parameters, and even if they do, the task appears to have exponential computational complexity if the model is non-linear. Causal probabilistic networks have both differential equation models and qualitative simulation as special cases, and they can provide both Bayesian and maximum-likelihood parameter estimates, in most cases in much less than exponential time. In addition, they can calculate the probabilities required for a decision-theoretical approach to medical decision support. The practical applicability of causal probabilistic networks to real medical problems is illustrated by a model of glucose metabolism which is used to adjust insulin therapy in type I diabetic patients.


2004 ◽  
Vol 37 (9) ◽  
pp. 487-492
Author(s):  
Y. Ramprasad ◽  
G.P. Rangaiah ◽  
S. Lakshminarayanan

1985 ◽  
Vol 54 (02) ◽  
pp. 413-414 ◽  
Author(s):  
Margarethe Geiger ◽  
Bernd R Binder

SummaryWe have demonstrated previously that fibrin enhanced plasmin formation by the vascular plasminogen activator was significantly impaired, when components isolated from the plasma of three uncontrolled diabetic patients (type I) were used to study plasminogen activation in vitro. In the present study it can be demonstrated that functional properties of the vascular plasminogen activators as well as of the plasminogens from the same three diabetic patients are significantly improved after normalization of blood sugar levels and improvement of HbAlc values. Most pronounced the Km of diabetic vascular plasminogen activator in the presence of fibrin returned to normal values, and for diabetic plasminogen the prolonged lag period until maximal plasmin formation occurred was shortened to almost control values. From these data we conclude that the observed abnormalities of in vitro fibrinolysis are not primarily associated with the diabetic disease, but might be secondary to metabolic disorders caused by diabetes.


Diabetes ◽  
1988 ◽  
Vol 37 (4) ◽  
pp. 462-466 ◽  
Author(s):  
U. Di Mario ◽  
F. Dotta ◽  
L. Crisa ◽  
E. Anastasi ◽  
D. Andreani ◽  
...  

Diabetes ◽  
1989 ◽  
Vol 38 (4) ◽  
pp. 524-533 ◽  
Author(s):  
H. Wahrenberg ◽  
F. Lonnqvist ◽  
P. Engfeldt ◽  
P. Arner
Keyword(s):  

Diabetes ◽  
1987 ◽  
Vol 36 (1) ◽  
pp. 73-79 ◽  
Author(s):  
W. L. Kupin ◽  
P. Cortes ◽  
F. Dumler ◽  
C. S. Feldkamp ◽  
M. C. Kilates ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document